Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens

Scientific Reports
Niels Peter H KnudsenElse Marie Agger

Abstract

The majority of vaccine candidates in clinical development are highly purified proteins and peptides relying on adjuvants to enhance and/or direct immune responses. Despite the acknowledged need for novel adjuvants, there are still very few adjuvants in licensed human vaccines. A vast number of adjuvants have been tested pre-clinically using different experimental conditions, rendering it impossible to directly compare their activity. We performed a head-to-head comparison of five different adjuvants Alum, MF59®, GLA-SE, IC31® and CAF01 in mice and combined these with antigens from M. tuberculosis, influenza, and chlamydia to test immune-profiles and efficacy in infection models using standardized protocols. Regardless of antigen, each adjuvant had a unique immunological signature suggesting that the adjuvants have potential for different disease targets. Alum increased antibody titers; MF59® induced strong antibody and IL-5 responses; GLA-SE induced antibodies and Th1; CAF01 showed a mixed Th1/Th17 profile and IC31® induced strong Th1 responses. MF59® and GLA-SE were strong inducers of influenza HI titers while CAF01, GLA-SE and IC31® enhanced protection to TB and chlamydia. Importantly, this is the first extensive attempt to ...Continue Reading

References

Apr 1, 1996·The Journal of Infectious Diseases·R C BrunhamF A Plummer
Aug 6, 2003·Expert Review of Vaccines·Audino Podda, Giuseppe Del Giudice
Oct 14, 2004·Immunology and Cell Biology·Nikolai Petrovsky, Julio César Aguilar
Feb 12, 2008·The Journal of Infectious Diseases·David I BernsteinHeather Hill
Feb 22, 2008·The Journal of Infectious Diseases·Frank FollmannMichael Theisen
Mar 8, 2008·Nature Reviews. Immunology·Robert A SederMario Roederer
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Grazia GalliFlora Castellino
Feb 28, 2009·Nature Reviews. Immunology·Philippa MarrackMichael W Munks
Mar 3, 2009·Expert Review of Vaccines·Ali M HarandiOle F Olesen
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Grazia GalliIain Stephenson
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas LindenstrømPeter Andersen
Feb 19, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hanne SchoenenRoland Lang
Oct 7, 2010·Expert Review of Vaccines·Hana El Sahly
Jan 25, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sucharitha BaluJuraj Ivanyi
Apr 22, 2011·Expert Review of Vaccines·Derek T O'HaganGiuseppe Del Giudice
Jul 22, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cheryl L DayWillem A Hanekom
Oct 15, 2011·The New England Journal of Medicine·Timo VesikariRalf Clemens
Oct 15, 2011·The Journal of Infectious Diseases·Suzanne E OhmitArnold S Monto
Feb 22, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elena CaproniEnnio De Gregorio
Oct 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Christopher H CleggSteven G Reed
Oct 23, 2012·Vaccine·Kohhei Tetsutani, Ken J Ishii
May 17, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas LindenstrømPeter Andersen

❮ Previous
Next ❯

Citations

Mar 5, 2016·Expert Review of Vaccines·Hong YuRobert C Brunham
Oct 8, 2016·Parasites & Vectors·Biniam Mathewos TebejeDonald P McManus
Dec 14, 2016·Scientific Reports·Thorunn A OlafsdottirAli M Harandi
Apr 5, 2017·Immunology·Jacqueline U McDonaldJohn S Tregoning
Dec 13, 2017·Human Vaccines & Immunotherapeutics·John S TregoningEkaterina Kinnear
Apr 16, 2018·The FEBS Journal·Natalia Muñoz-Wolf, Ed C Lavelle
Jan 10, 2018·Frontiers in Immunology·Anouk C M PlatteelStefan H E Kaufmann
Dec 13, 2017·Frontiers in Immunology·Spencer J Williams
Jun 5, 2018·AIDS Research and Human Retroviruses·Sallie PermarKristina De Paris
Jul 18, 2018·Human Vaccines & Immunotherapeutics·Eun-Ju Ko, Sang-Moo Kang
Sep 4, 2018·Scandinavian Journal of Immunology·Patricia Méndez-Samperio
Aug 15, 2018·Infection and Immunity·Rajesh ManiNirupama Banerjee
Aug 10, 2018·Journal of Virology·Bonnie PhillipsKristina De Paris
Oct 3, 2018·Human Vaccines & Immunotherapeutics·Rolf BilleskovJay A Berzofsky
Nov 21, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher T JohndrowSteven A Porcelli
Jan 9, 2019·Glycoconjugate Journal·Bridget L StockerMattie S M Timmer
Aug 10, 2018·American Journal of Respiratory and Critical Care Medicine·Sara SulimanUNKNOWN H56-035 Trial Group
Feb 15, 2019·PLoS Neglected Tropical Diseases·Susan L BaldwinRhea N Coler
Jan 10, 2019·ILAR Journal·Signe Tandrup SchmidtDennis Christensen
Jun 9, 2019·The Journal of Experimental Medicine·Danika L HillMichelle A Linterman
May 14, 2016·Oncotarget·Julie S LefebvreLaura Haynes
May 22, 2020·European Journal of Immunology·Huibin LvChris K P Mok
Aug 26, 2020·Expert Opinion on Drug Discovery·Fakhriedzwan IdrisSylvie Alonso
Oct 27, 2016·Frontiers in Immunology·Annalisa CiabattiniDonata Medaglini
Aug 25, 2020·Plasma Processes and Polymers·Hager MohamedVandana Miller
Mar 24, 2018·F1000Research·Gerald VossHelen A Fletcher
Oct 5, 2017·Frontiers in Immunology·Natalie E NieuwenhuizenStefan H E Kaufmann

❮ Previous
Next ❯

Methods Mentioned

BETA
flow filtration
IEC
ELISA
Flow cytometry
FACS
fluorescence microscopy

Software Mentioned

Prism
DIVA
Flowjo
SE
GraphPad
Excel
GLA

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.